MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN

miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7

(2015) Chuanyi Zhou et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment

(2015) Bing Feng et al.   CLINICAL SCIENCE

MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer

(2015) Eduardo Tormo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis

(2015) L Roca-Alonso et al.   Cell Death & Disease

Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)

(2014) Yusuf Tutar   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

miR-92a family and their target genes in tumorigenesis and metastasis

(2014) Molin Li et al.   EXPERIMENTAL CELL RESEARCH

Recent Advances in Protection against Doxorubicin-induced Toxicity

(2014) Rade Injac et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

(2013) Chifumi Ohyagi-Hara et al.   AMERICAN JOURNAL OF PATHOLOGY

miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation

(2013) Gengsheng He et al.   BIOMEDICINE & PHARMACOTHERAPY

STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells

(2013) H-Y Lin et al.   BRITISH JOURNAL OF CANCER

MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN

(2013) Guangjun Zhang et al.   DIGESTIVE DISEASES AND SCIENCES

miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells

(2013) Shanliang Zhong et al.   GENE

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A

(2012) X. Zhu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Correction: In Vitro Evolution of Allergy Vaccine Candidates, with Maintained Structure, but Reduced B Cell and T Cell Activation Capacity

(2012) Ola B. Nilsson et al.   PLoS One

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

(2012) S Yoshizawa et al.   Blood Cancer Journal

miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer

(2011) Akihiko Tsuchida et al.   CANCER SCIENCE

MicroRNA in lung cancer diagnostics and treatment

(2011) Marcin Skrzypski et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma

(2011) Kazuma Ohyashiki et al.   PLoS One

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN

(2010) Zhang Chun-zhi et al.   BMC CANCER

MicroRNA and drug resistance

(2010) J Ma et al.   CANCER GENE THERAPY

microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin

(2010) Zhao-li Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

(2009) Michela Garofalo et al.   CANCER CELL

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types

(2009) Richard Hummel et al.   EUROPEAN JOURNAL OF CANCER